# Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy

> **NCT01743014** · PHASE4 · UNKNOWN · sponsor: **AHEPA University Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Diabetes Type 2
- Diabetic Nephropathy
- Vascular Disease

## Interventions

- **DRUG:** Ramipril
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT01743014
- **Lead sponsor:** AHEPA University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-07
- **Primary completion:** 2014-07
- **Final completion:** 2015-07
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2012-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01743014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01743014, "Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01743014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*